恒瑞医药11月20日斥资1274.32万元回购20.99万股A股

Core Viewpoint - Heng Rui Medicine (600276)(01276) announced a share buyback plan, indicating confidence in its stock value and future prospects [1] Summary by Category Company Actions - The company plans to repurchase 209,900 A-shares at a total cost of 12.7432 million RMB [1] - The buyback price per share ranges from 60.58 to 60.78 RMB [1] Financial Implications - The total expenditure for the buyback reflects a strategic move to enhance shareholder value [1]